Press Releases BRAIN Biotech AG

Equities

BNN

DE0005203947

Environmental Services & Equipment

Market Closed - Xetra Other stock markets 11:35:25 2026-02-13 am EST			5-day change	1st Jan Change
2.260 ^EUR	+1.35%		+0.89%	-10.32%

Jan. 14	BRAIN Biotech AG Provides Revenue Guidance for the Year 2025/2026	CI
Jan. 13	BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2025	CI

Press Releases

Jan. 14	BRAIN Biotech : Management Statement 12M 2024/25 (BRAIN Managementstatement 12M 2024 25)	PU
Jan. 14	BRAIN Biotech : ESG Data Sheet 2023/24	PU
Jan. 14	FY 2024/25: BRAIN Biotech AG benefits from successful monetization of projects and strong corporate cost control	EQ
Jan. 06	BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	EQ
25-10-20	BRAIN Biotech AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	EQ
25-10-02	BRAIN Biotech AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	EQ
25-09-09	BRAIN Biotech : Johan Jansén-Storbacka takes over as head of BRAINBiocatalysts' enzyme product business	PU
25-09-03	BRAIN Biotech AG appoints Johan Jansén-Storbacka as Executive Vice President of the BRAINBiocatalysts´ enzyme products business	EQ
25-08-28	BRAIN Biotech : Management Statement 9M 2024/25 (BRAIN Management Statement 9M24 25)	PU
25-08-28	BRAIN Biotech reports dynamic Q3 revenue growth in core segment BRAINBiocatalysts	EQ
25-08-28	BRAIN Biotech : Quarterly Statement as of 30 June 2025 (9M)	PU
25-08-25	Corbion and BRAIN Biotech team to shape the future of innovation in nature-based ingredient technologies	EQ
25-07-23	Experienced biotechnology expert joins the Supervisory Board of BRAIN Biotech AG	EQ
25-05-28	BRAIN Biotech : Management Statement 6M 2024/25 (BRAIN IR Management 6M 2024 25)	PU
25-05-28	BRAIN Biotech : Half-year report as of 31 March 2025 (6M)	PU
25-05-28	BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25	EQ
25-05-20	BRAIN Biotech announces buy-out of minorities, new continental European production site, and expansion of its Baking Application Center	EQ
25-05-19	AFR: BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	EQ
25-05-12	BRAIN Biotech : IR Presentation May 2025 (20250512 IR BRAIN May2025)	PU
25-05-09	BRAIN Biotech : IR Präsentation May 2025 (20250506 IR BRAIN 2025May)	PU
25-05-07	BRAIN Biotech : IR Presentation May 2025 (20250506 IR BRAIN 2025)	PU
25-04-30	BRAIN Biotech AG reports preliminary Q2 figures and forecasts a more conservative development for the second half of the fiscal year 2024/25	EQ
25-03-18	Results of the 2025 Annual General Meeting for the 2023/24 financial year of BRAIN Biotech AG	EQ
25-03-03	DD: BRAIN Biotech AG: Michael Schneiders, buy	EQ
25-02-26	BRAIN Biotech : Management Statement 3M 2024/25 (BRAIN IR AnalystCall3M 2024 25)	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Press Releases BRAIN Biotech AG

Equities

BNN

DE0005203947

Environmental Services & Equipment

Press Releases

Filters